Health session comment peice: Dr Robert Langer outlines his GGCS keynote talk on Biomaterials and biotechnology

Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering


This session will cover the contributions of engineering research to the frontiers of healthcare, from bioengineering, to new surgery and imaging techniques to regenerative and personalized medicine.  In particular, this talk will examine three areas.  The first area is nanotechnology and how it can be potentially used to target drugs to specific sites of the body, such as tumours.  We will discuss how nanoparticles can be designed to target them to tumours, including initial human clinical trials.  The second area involves novel implantable microchips that can deliver drugs by remote control.  Tiny chips can be placed in the body and the release of drugs can be activated by a cell phone or computer.  Initial human trials in this area will also be discussed.  The third area involves the combination of polymers and mammalian cells to potentially create new tissues such as skin, cartilage or even spinal cords.  Human and animal trials will be examined.

By Dr Robert Langer – GGCS health session keynote speaker and panellist

David H. Koch Institute Professor, MIT




This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s